Table 3.
Crude prevalence of antimicrobial use by ward specialty/subclass/hospital type; total results for Global and ECDC-PPS 2017 (Belgium, acute care hospitals)
| Patients with at least one antimicrobial | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| N | Crude prevalence (%) | 95% CI | N | Crude prevalence (%) | 95% CI | N | Crude prevalence (%) | 95% CI | N | Crude prevalence (%) | 95% CI | |
| Ward specialty | Total | Medicine | Surgery | ICU | ||||||||
| All patients | 7577 | 27.1 | 26.5–27.6 | 4886 | 24.6 | 24.0–25.2 | 1988 | 29.6 | 28.5–30.7 | 703 | 51.0 | 48.4–53.7 |
| Adultsa | 7095 | 27.1 | 26.6–27.7 | 4461 | 24.4 | 23.8–25.1 | 1966 | 29.4 | 28.3–30.5 | 668 | 55.1 | 52.3–57.9 |
| Childrena | 430 | 32.4 | 29.9–34.9 | 393 | 31.6 | 29.0–34.2 | 22 | 47.8 | 33.4–62.3 | 15 | 38.5 | 23.2–53.7 |
| Neonatesa | 52 | 9.8 | 7.3–12.3 | 32 | 7.9 | 5.3–10.5 | 0 | 20 | 15.8 | 9.4–22.1 | ||
| Per antimicrobial subclass | ||||||||||||
| A07AA | 59 | 0.21 | 0.16–0.26 | 52 | 0.26 | 0.19–0.33 | 2 | 0.03 | 0.00–0.07 | 5 | 0.36 | 0.05–0.68 |
| D01BA | 6 | 0.02 | 0.00–0.04 | 4 | 0.02 | 0.00–0.04 | 2 | 0.03 | 0.00–0.07 | 0 | ||
| J01 | 7323 | 26.2 | 25.6–26.7 | 4664 | 23.4 | 22.8–24.0 | 1973 | 29.3 | 28.3–30.4 | 686 | 49.8 | 47.1–52.4 |
| J02 | 357 | 1.27 | 1.14–1.41 | 270 | 1.36 | 1.20–1.52 | 36 | 0.54 | 0.36–0.71 | 51 | 3.70 | 2.70–4.70 |
| J04A | 79 | 0.28 | 0.22–0.34 | 41 | 0.21 | 0.14–0.27 | 35 | 0.52 | 0.35–0.69 | 3 | 0.22 | 0.00–0.46 |
| J05b | 95 | 0.34 | 0.27–0.41 | 87 | 0.44 | 0.35–0.53 | 1 | 0.01 | 0.00–0.04 | 7 | 0.51 | 0.13–0.88 |
| P01AB | 149 | 0.53 | 0.45–0.62 | 118 | 0.59 | 0.49–0.70 | 27 | 0.40 | 0.25–0.55 | 4 | 0.29 | 0.01–0.57 |
| Per hospital typec | ||||||||||||
| Primary | 4866 | 27.0 | 26.3–27.6 | 3135 | 24.4 | 23.6–25.1 | 1327 | 30.1 | 28.7–31.4 | 404 | 53.1 | 49.5–56.6 |
| Secondary | 1768 | 26.1 | 25.0–27.1 | 1143 | 23.1 | 21.9–24.3 | 455 | 30.7 | 28.4–33.1 | 170 | 48.3 | 43.1–53.5 |
| Tertiary | 907 | 29.5 | 27.9–31.1 | 583 | 28.9 | 26.9–30.9 | 203 | 24.8 | 21.9–27.8 | 121 | 51.0 | 44.7–57.4 |
CI Confidence interval, ECDC European Centre for Disease Prevention and Control, ICU Intensive care units, N Total number of patients with at least one antimicrobial, PPS Point prevalence survey
A07AA intestinal antiinfectives, D01BA antifungals for systemic use, J01 antibacterials for systemic use, J02 antimycotics for systemic use, J04A drugs for treatment of tuberculosis, J05 antivirals agents, P01AB nitroimidazole-derived antiprotozoals
aThe classification of adults, children and neonates is based on the ward type
bJ05 only included in the Global-PPS
cResults of the specialized hospital (N = 1) not shown